Kevin Biglan is a Neurology physician affiliated with Eli Lilly. OpenAlex indexes 150 publications with 12,310 citations (h-index 43); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
919 Westfall Rd
Bldg C, Suite 215
Rochester, NY 146182638
Telephone
585-341-7500Registry record last updated 5 Jul 2023.
Clinical trials
- Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)
Sponsor: Johns Hopkins University
- Pilot Randomized Controlled Trial of Telemedicine for Individuals With Parkinson Disease in a Rural Population
Sponsor: University of Rochester
- A Pilot, Randomized Controlled Trial of Group Visits for Persons With Parkinson's Disease
Sponsor: University of Rochester
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Cholinesterase Inhibitor100%Rivastigmine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2014–2015 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Epidemiology and economic burden of Lewy body dementia in the United States
Current Medical Research and Opinion
2022 - Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials
Alzheimer s Research & Therapy
2020 - Feasibility, Reliability, and Value of Remote Video-Based Trial Visits in Parkinson’s Disease
Journal of Parkinson s Disease
2020 - Design of a virtual longitudinal observational study in Parkinson’s disease (AT‐HOME PD)
Annals of Clinical and Translational Neurology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Flora Sam, MD
Eli Lilly
Alessandro Biffi, MD
Eli Lilly
Ann Hake, MD
Eli Lilly
Ramon Tiu, MD
Eli Lilly
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”